- info@novaerus.ie
- +353 (1) 255 1536
HNRC implemented the NV200, NV400, and NV900 units in selected areas.
This study compares the total number of repeat infections, nosocomial C. difficile infections, and nosocomial respiratory infections before and after implementation of the Novaerus technology.
A 24-month review was conducted to evaluate the results of implementation.
The impact of Novaerus (NV1050) air purifier on aerosolised M. smegmatis was conducted in a 30 m3 environmental testing chamber. The test chamber was preconditioned to 20 ± 3 °C and 55 ± 5% relative humidity. These conditions were maintained throughout the test and control runs. Prior to each run, the test chamber was decontaminated by scrubbing the walls and surfaces.
The results achieved during the testing show that the NV1050 was able to reduce the concentration of M. smegmatis artificially aerosolised by 95% within the first 15 minutes and this rose to 97% after 30 minutes of A/C operation.
About Us
Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and odour.
The patented plasma NanoStrike technology used in Novaerus portable devices was invented in Ireland in 2006.
Novaerus Devices
Stay Connected to Novaerus
To keep up to date with all developments and for the latest research and scientifically proven results please follow us on LinkedIn, Facebook and Youtube.
